UBS raised the firm’s price target on Viavi (VIAV) to $17 from $12 and keeps a Neutral rating on the shares. AI and data center demand drove a strong quarter and guidance, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV: